SIROHIA & SONS | EVOQ REMEDIES LTD. | SIROHIA & SONS/ EVOQ REMEDIES LTD. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | - | - | - | View Chart |
P/BV | x | 0.4 | 0.7 | 54.7% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
SIROHIA & SONS EVOQ REMEDIES LTD. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
SIROHIA & SONS Mar-24 |
EVOQ REMEDIES LTD. Mar-24 |
SIROHIA & SONS/ EVOQ REMEDIES LTD. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 10 | 19 | 49.1% | |
Low | Rs | 6 | 9 | 68.2% | |
Sales per share (Unadj.) | Rs | 0 | 3.0 | 0.0% | |
Earnings per share (Unadj.) | Rs | 0.1 | 0.3 | 15.5% | |
Cash flow per share (Unadj.) | Rs | 0.1 | 0.3 | 17.3% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 27.4 | 18.6 | 147.8% | |
Shares outstanding (eoy) | m | 10.26 | 13.60 | 75.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 4.7 | - | |
Avg P/E ratio | x | 149.8 | 42.0 | 356.8% | |
P/CF ratio (eoy) | x | 131.1 | 41.3 | 317.2% | |
Price / Book Value ratio | x | 0.3 | 0.8 | 37.1% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 79 | 190 | 41.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 0 | 1 | 61.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 41 | 0.0% | |
Other income | Rs m | 3 | 23 | 12.9% | |
Total revenues | Rs m | 3 | 63 | 4.6% | |
Gross profit | Rs m | -3 | -16 | 16.4% | |
Depreciation | Rs m | 0 | 0 | 114.3% | |
Interest | Rs m | 0 | 0 | - | |
Profit before tax | Rs m | 0 | 6 | 2.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 2 | -22.6% | |
Profit after tax | Rs m | 1 | 5 | 11.7% | |
Gross profit margin | % | 0 | -40.4 | - | |
Effective tax rate | % | -227.0 | 26.0 | -872.3% | |
Net profit margin | % | 0 | 11.2 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 240 | 368 | 65.2% | |
Current liabilities | Rs m | 0 | 116 | 0.3% | |
Net working cap to sales | % | 0 | 622.3 | - | |
Current ratio | x | 727.7 | 3.2 | 22,954.4% | |
Inventory Days | Days | 0 | 0 | - | |
Debtors Days | Days | 0 | 1,569 | - | |
Net fixed assets | Rs m | 41 | 0 | 29,357.1% | |
Share capital | Rs m | 103 | 136 | 75.4% | |
"Free" reserves | Rs m | 179 | 116 | 153.7% | |
Net worth | Rs m | 281 | 252 | 111.5% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 281 | 369 | 76.3% | |
Interest coverage | x | 0 | 0 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0 | 0.1 | 0.0% | |
Return on assets | % | 0.2 | 1.2 | 15.2% | |
Return on equity | % | 0.2 | 1.8 | 10.4% | |
Return on capital | % | 0.1 | 2.4 | 2.4% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 0 | 53 | 0.5% | |
From Investments | Rs m | NA | NA | -0.0% | |
From Financial Activity | Rs m | NA | -53 | -0.0% | |
Net Cashflow | Rs m | 0 | 0 | -80.0% |
Indian Promoters | % | 50.1 | 11.2 | 447.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 49.9 | 88.8 | 56.2% | |
Shareholders | 158 | 1,577 | 10.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare SIROHIA & SONS With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA MSTC
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | SIROHIA & SONS | EVOQ REMEDIES LTD. |
---|---|---|
1-Day | -5.00% | 0.00% |
1-Month | -9.52% | -7.47% |
1-Year | 44.21% | -36.55% |
3-Year CAGR | 5.93% | -32.48% |
5-Year CAGR | 3.52% | -21.00% |
* Compound Annual Growth Rate
Here are more details on the SIROHIA & SONS share price and the EVOQ REMEDIES LTD. share price.
Moving on to shareholding structures...
The promoters of SIROHIA & SONS hold a 50.1% stake in the company. In case of EVOQ REMEDIES LTD. the stake stands at 11.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SIROHIA & SONS and the shareholding pattern of EVOQ REMEDIES LTD..
Finally, a word on dividends...
In the most recent financial year, SIROHIA & SONS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
EVOQ REMEDIES LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of SIROHIA & SONS, and the dividend history of EVOQ REMEDIES LTD..
Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.